GlassScriptPhysician profile
Richard Henrys
NPI 1750347522
$598.83
in general payments reported to CMS, 2019-2025
9 companies · $84.34 in 2025
The $84.34 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.67 · 2020: $88.56 · 2021: $90.09 · 2022: $67.70 · 2023: $87.64 · 2024: $166 · 2025: $84.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $165.83 | 2024 | |
| Stryker Corporation | $148.68 | 2020-2023 | T2 Alpha, Variax |
| Smith+Nephew, INC. | $93.38 | 2022-2025 | Pico 14 |
| Si-Bone, INC. | $62.93 | 2021 | |
| Camber Spine Technologies LLC | $55.76 | 2021-2022 | |
| Heraeus Medical, LLC. | $24.36 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $19.31 | 2025 | Exparel |
| Biocomposites INC | $14.67 | 2019 | |
| Theragen, INC. | $13.91 | 2023 | Actastim-S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Henrys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.